Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Jan;9(1):71-5.
doi: 10.1007/s11908-007-0025-0.

HIV-1 vaccine development: progress and prospects

Anna R Thorner  1 , Dan H Barouch
Affiliations

HIV-1 vaccine development: progress and prospects

Anna R Thorner et al. Curr Infect Dis Rep. 2007 Jan.

Abstract

The development of a prophylactic HIV-1 vaccine is a global health priority. It has proven extraordinarily challenging, however, to develop immunogens that elicit broadly reactive HIV-1-specific neutralizing antibodies. As a result, most HIV-1 vaccine candidates in development focus on generating virus-specific cellular immune responses. Both plasmid DNA vaccines and recombinant live vectors have been shown to elicit cellular immune responses, and vaccine candidates based on these technologies are now being evaluated for safety, immunogenicity, and efficacy in advanced phase clinical trials. This review examines the progress and prospects of these vaccine strategies.

PubMed Disclaimer

References

    1. Nat Med. 1999 Nov;5(11):1270-6 - PubMed
    1. J Virol. 2005 Nov;79(22):14161-8 - PubMed
    1. J Immunol. 2003 Feb 1;170(3):1416-22 - PubMed
    1. Nature. 2005 Apr 28;434(7037):1093-7 - PubMed
    1. Nature. 2002 Jan 17;415(6869):335-9 - PubMed

LinkOut - more resources